Molecular cloning of polyoma virus DNA in Escherichia coli: plasmid vector system.

PubWeight™: 1.74‹?› | Rank: Top 3%

🔗 View Article (PMID 217087)

Published in Science on March 02, 1979

Authors

M A Israel, H W Chan, W P Rowe, M A Martin

Articles citing this

Direct transfer of cloned genes from bacteria to mammalian cells. Proc Natl Acad Sci U S A (1980) 6.21

Cloning of human papilloma virus genomic DNAs and analysis of homologous polynucleotide sequences. J Virol (1980) 3.34

Identification of ecotropic proviral sequences in inbred mouse strains with a cloned subgenomic DNA fragment. Proc Natl Acad Sci U S A (1980) 3.19

Identification and cloning of endogenous retroviral sequences present in human DNA. Proc Natl Acad Sci U S A (1981) 2.26

RNA:DNA complex formation upon transcription of immunoglobulin switch regions: implications for the mechanism and regulation of class switch recombination. Nucleic Acids Res (1995) 1.93

Cloned human polyomavirus JC DNA can transform human amnion cells. J Virol (1980) 1.50

Biological and biochemical studies of African green monkey lymphotropic papovavirus. J Virol (1982) 1.46

Comparison of infectious JC virus DNAs cloned from human brain. J Virol (1983) 1.41

Detection and cloning of murine leukemia virus-related sequences from African green monkey liver DNA. J Virol (1981) 1.38

Analysis of JC virus DNA purified directly from human progressive multifocal leukoencephalopathy brains. J Virol (1981) 1.36

Regulation of pp60c-src synthesis by inducible RNA complementary to c-src mRNA in polyomavirus-transformed rat cells. Mol Cell Biol (1986) 1.15

Class I defective herpes simplex virus DNA as a molecular cloning vehicle in eucaryotic cells. J Virol (1983) 1.08

Polyoma large tumor antigen is not required for tumorigenesis mediated by viral DNA. Proc Natl Acad Sci U S A (1980) 1.04

Strand specificity in the transcriptional targeting of recombination at immunoglobulin switch sequences. Proc Natl Acad Sci U S A (1995) 1.04

A cloned polyoma DNA fragment representing the 5' half of the early gene region is oncogenic. J Virol (1980) 0.96

Identification of ecotropic proviral sequences in high- and low-ecotropic-virus-producing mouse strains. J Virol (1982) 0.91

Asynchronous bidirectional replication of polyoma virus DNA. J Virol (1982) 0.89

Isolation and characterization of replication forks from discrete regions of the polyoma genome. J Virol (1982) 0.89

Two defective DNAs of human polyomavirus JC adapted to growth in human embryonic kidney cells. J Virol (1982) 0.88

Analysis of pp60c-src protein kinase activity in hamster embryo cells transformed by simian virus 40, human adenoviruses, and bovine papillomavirus 1. J Virol (1986) 0.85

Polyomavirus minichromosomes: associated DNA topoisomerase II and DNA ligase activities. J Virol (1984) 0.79

Structural analysis of integrated polyomavirus DNA in a polyomavirus-induced hamster tumor cell line. J Virol (1983) 0.78

Articles by these authors

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol (1986) 37.70

Plaque assay techniques for murine leukemia viruses. Virology (1970) 29.21

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A (1987) 18.91

A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proc Natl Acad Sci U S A (1977) 13.96

In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol (1988) 12.52

Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science (1986) 11.74

Host-range restrictions of murine leukemia viruses in mouse embryo cell cultures. J Virol (1970) 11.14

Clonal cells lines from a feral mouse embryo which lack host-range restrictions for murine leukemia viruses. Virology (1975) 10.56

A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occurring viruses. J Exp Med (1971) 9.81

Isolation of naturally occurring viruses of the murine leukemia virus group in tissue culture. J Virol (1969) 9.39

Naturally occurring murine leukemia viruses in wild mice: characterization of a new "amphotropic" class. J Virol (1976) 9.33

Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med (1988) 9.21

Murine leukemia virus: high-frequency activation in vitro by 5-iododeoxyuridine and 5-bromodeoxyuridine. Science (1971) 8.78

Complement fixation and tissue culture assays for mouse leukemia viruses. Proc Natl Acad Sci U S A (1965) 7.77

The HIV 'A' (sor) gene product is essential for virus infectivity. Nature (1987) 7.51

Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc Natl Acad Sci U S A (1966) 7.35

Quantitation of Simian virus 40 sequences in African green monkey, mouse and virus-transformed cell genomes. J Mol Biol (1971) 7.10

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat Med (1999) 6.91

p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol (1995) 6.87

Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants. Proc Natl Acad Sci U S A (1977) 6.80

Production of altered cell foci in tissue culture by defective Moloney sarcoma virus particles. Proc Natl Acad Sci U S A (1966) 6.79

Studies of genetic transmission of murine leukemia virus by AKR mice. I. Crosses with Fv-1 n strains of mice. J Exp Med (1972) 6.52

Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc Natl Acad Sci U S A (1988) 6.33

A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science (1988) 6.30

The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J Virol (1990) 6.08

The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors. J Virol (1988) 5.94

Quantitative studies of naturally occurring murine leukemia virus infection of AKR mice. J Exp Med (1972) 5.64

A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus. J Exp Med (1971) 5.50

Rescue of the defective genome of Moloney sarcoma virus from a noninfectious hamster tumor and the production of pseudotype sarcoma viruses with various murine leukemia viruses. Proc Natl Acad Sci U S A (1966) 5.34

A rapid method for detecting and mapping homology between heterologous DNAs. Evaluation of polyomavirus genomes. J Biol Chem (1979) 5.32

Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol (1998) 5.31

Quantitation of human immunodeficiency virus type 1 infection kinetics. J Virol (1993) 5.17

Mixed culture cytopathogenicity: a new test for growth of murine leukemia viruses in tissue culture. Proc Natl Acad Sci U S A (1969) 5.06

Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation. Cell (1984) 5.05

Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J Virol (1992) 5.05

Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus. J Virol (1986) 5.05

Lymphomagenicity of recombinant mink cell focus-inducing murine leukemia viruses. J Exp Med (1980) 5.05

A map of simian virus 40 transcription sites expressed in productively infected cells. J Mol Biol (1973) 5.02

Transfection of molecularly cloned Friend murine leukemia virus DNA yields a highly leukemogenic helper-independent type C virus. J Virol (1980) 4.91

Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc Natl Acad Sci U S A (1986) 4.89

Role for the 3' end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses. Proc Natl Acad Sci U S A (1983) 4.68

Studies on nondefective adenovirus-simian virus 40 hybrid viruses. I. A newly characterized simian virus 40 antigen induced by the Ad2+ND 1 virus. J Virol (1971) 4.62

Changes in expression of murine leukemia virus antigens and production of xenotropic virus in the late preleukemic period in AKR mice. Proc Natl Acad Sci U S A (1976) 4.52

Qualitative and quantitative studies of AKR-type murine leukemia virus sequences in mouse DNA. Cold Spring Harb Symp Quant Biol (1975) 4.49

Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus. Proc Natl Acad Sci U S A (1986) 4.43

Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J Virol (1994) 4.40

Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol (1995) 4.27

Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J Virol (1996) 4.08

Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J Virol (1995) 4.06

Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J Virol (1995) 3.95

Molecular cloning of the Harvey sarcoma virus closed circular DNA intermediates: initial structural and biological characterization. J Virol (1979) 3.90

Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J Virol (1989) 3.90

Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol (1993) 3.90

Genetic mapping of a murine leukemia virus-inducing locus of AKR mice. Science (1972) 3.81

Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. Science (1986) 3.80

Beta 2-microglobulin expression in human embryonal neuroblastoma reflects its developmental regulation. Cancer Res (1990) 3.75

Patterns of Simian Virus 40 DNA transcription after acute infection of permissive and nonpermissive cells. Proc Natl Acad Sci U S A (1972) 3.65

Identification of DNA fragments carrying ecotropic proviruses of AKR mice. Proc Natl Acad Sci U S A (1979) 3.64

Genetic recombination of human immunodeficiency virus. J Virol (1989) 3.61

Definitive evidence that the murine C-type virus inducing locus Akv-1 is viral genetic material. Proc Natl Acad Sci U S A (1975) 3.51

Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature (1985) 3.50

Studies of genetic transmission of murine leukemia virus by AKR mice. II. Crosses with Fv-1 b strains of mice. J Exp Med (1972) 3.47

Studies of adenovirus SV40 hybrid viruses. II. Defectiveness of the hybrid particles. J Exp Med (1965) 3.45

Serologic evidence for human infection with adenovirus-associated viruses. J Natl Cancer Inst (1968) 3.44

The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J Virol (1989) 3.36

Cloning of human papilloma virus genomic DNAs and analysis of homologous polynucleotide sequences. J Virol (1980) 3.34

SV40 gene activity during lytic infection and in a series of SV40 transformed mouse cells. Proc Natl Acad Sci U S A (1969) 3.30

Noninfectious AKR mouse embryo cell lines in which each cell has the capacity to be activated to produce infectious murine leukemia virus. Virology (1971) 3.26

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA (1991) 3.25

Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proc Natl Acad Sci U S A (1977) 3.25

Leukemia virus genomes in the chromosomal DNA of the mouse. Harvey Lect (1978) 3.19

Identification of ecotropic proviral sequences in inbred mouse strains with a cloned subgenomic DNA fragment. Proc Natl Acad Sci U S A (1980) 3.19

Molecular cloning of polyoma virus DNA in Escherichia coli: lambda phage vector system. Science (1979) 3.17

Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types. J Virol (1991) 3.12

Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120. J Virol (1994) 3.07

Envelope and long terminal repeat sequences of a cloned infectious NZB xenotropic murine leukemia virus. J Virol (1985) 3.06

Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J Virol (1992) 3.06

Identification and partial characterization of new antigens from simian virus 40-transformed mouse cells. J Virol (1979) 3.04

Characterization of murine leukaemia virus-specific DNA present in normal mouse cells. Nat New Biol (1973) 2.98

Correlation of early murine leukemia virus titer and H-2 type with spontaneous leukemia in mice of the BALB/c times AKR cross: a genetic analysis. J Exp Med (1975) 2.98

Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. Proc Natl Acad Sci U S A (2001) 2.96

Evidence that the AKR murine-leukemia-virus genome is complete in DNA of the high-virus AKR mouse and incomplete in the DNA of the "virus-negative" NIH mouse. Proc Natl Acad Sci U S A (1974) 2.95

A major genetic locus affecting resistance to infection with murine leukemia viruses. IV. Dose-response relationships in Fv-1-sensitive and resistant cell cultures. Virology (1975) 2.95

Rapid viral induction of plasmacytomas in pristane-primed BALB-c mice. Science (1973) 2.94

AKR murine leukemia virus genome: frequency of sequences in DNA of high-, low-, and non-virus-yielding mouse strains. Proc Natl Acad Sci U S A (1974) 2.91

Genetic factors in the natural history of murine leukemia virus infection: G. H. A. Clowes Memorial Lecture. Cancer Res (1973) 2.88

Nucleic acid homology studies of adenovirus type 7-SV40 interactions. Proc Natl Acad Sci U S A (1966) 2.86

Studies of adenovirus SV40 hybrid viruses. I. Assay system and further evidence for hybridization. J Exp Med (1965) 2.85

Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J Virol (1987) 2.84

The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection. J Biol Chem (1995) 2.70

Common methionine-tryptic peptides near the amino-terminal end of primate papovavirus tumor antigens. Proc Natl Acad Sci U S A (1978) 2.63

Biophysical evidence for linkage of adenovirus and SV40 DNA's in adenovirus 7-SV40 hybrid particles. Proc Natl Acad Sci U S A (1966) 2.61